Status:
UNKNOWN
Catheter Ablation of Arrhythmias With High Density Mapping System in the Real World Practice.
Lead Sponsor:
Azienda Ospedaliera Pugliese Ciaccio
Conditions:
Cardiac Arrhythmias
Eligibility:
All Genders
Brief Summary
The CHARISMA study is a non-randomized, multicenter, prospective study in which consecutive patients indicated for arrhythmia will be enrolled. Patients can be treated with any market released cathet...
Eligibility Criteria
Inclusion
- Patients who are eligible for ablation procedure of atrial and ventricular arrhythmia;
- Patients who are able to sign an authorization to use and disclose health information and capable of providing informed consent.
- Patients who are willing and capable to attend scheduled follow-up visits at the clinical investigational center for at least 12 months
Exclusion
- Patients who are currently enrolled in another clinical study that would directly interfere with the clinical practice of the investigational center
Key Trial Info
Start Date :
May 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03793998
Start Date
May 1 2018
End Date
January 1 2024
Last Update
January 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Pugliese-Ciaccio
Catanzaro, Italy, 88100